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ABSTRACT 
Objective: To develop simplified, accurate and precise visible spectrophotometric strategies for the assay of chlorphenoxamine hydrochloride 
(CPX) in pure drug and in its pharmaceutical preparations.  
Methods: The described methods depended on the formation of charge-transfer (CT) complexes of intense color between CPX as donor with three 
π-acceptors, chloranilic acid (CLA), 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), and 7,7,8,8-tetracyanoquinodimethane (TCNQ) and the 
colored reaction products were estimated spectrophotometrically at 520 nm, 460 nm and 840 nm for CLA, DDQ, and TCNQ complexes, individually. 
All the optimum conditions were established. The proposed methods were validated in term of linearity, limit of detection as per the international 
conference on harmonization guidelines ICH Q2 (R1).  
Results: The complexes obeyed Beer’s law in the concentration range of 16-144, 6-54 and 4-76 μg/mlwith molar absorptivity at 0.30×10
* 
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 l/mol/cm for CLA, DDQ, and TCNQ, individually. According to Benesi-Hildebrand plots, the association constants and changes of 
standard free energy were determined. 1:1 was the ratio of composition of the formed CT-complex.  
Conclusion: The obtained results revealed that the developed method can be applied successfully for the determination of CPX in drug formulations 
samples with good accuracy and precision. 




Chlorphenoxamine hydrochloride (CPX) is a quick acting antiallergic 
agent with antipruritic properties and pleasantly cooling and 
sedative effect. Chemically, it is 2-[1-(4-chlorophenyl)-1-
phenylethoxyl]-N, N-dimethylethanamine hydrochloride. (Molecular 
formula C18H23Cl2NO as in fig. 1 and molecular weight 340.29 g/mol) 
[1]. In recent years, a few analytical techniques have been accounted 
on the determination of (CPX) in pure and in tablet dosage forms 
such as potentiometric [2], spectrophotometric [3-6], derivative 
spectrophotometric [7-9], polarography [10] and differential pulse 
voltammetry [11]. Chromatographic methods including, TLC [12], GC 
[13] and LC [14] were also reported. These methods are costly, 
complicated, and time-consuming and require entirely controlled 
reaction conditions. Many of these methods are less sensitive. 
 
 
Fig. 1: Chemical structure of chlorphenoxamine hydrochloride 
 
The purpose of the present work was the development of a simple, 
economical, accurate, sensitive, time-saving and environmental 
friendly spectrophotometric techniques for the determination of CPX 
in bulk and in pharmaceutical formulation through the formation of 
charge transfer complexation reaction between CPX as n-electron 
donor and CLA, (DDQ), and (TCNQ) as π-acceptors. These techniques 
involved the formation of the intense color CT complexes between 
(CPX) and (CLA), (DDQ), and (TCNQ) by using acetonitrile as a proper 
solvent. The results obtained were compared with those obtained 
from the reference methods and this indicates that there was no 
significant difference between proposed and reference methods. The 
evolution of the standard free energy changes (ΔG °) and association 
constant (KCT) have been done. The standard conditions and the 
application of the proposed methods to the determination of CPX in 
the pharmaceutical formulation have established.  
MATERIALS AND METHODS 
Apparatus 
All the absorption spectral measurements were made using 
Shimadzu UV-160A, UV-VIS double beam spectrophotometer with 
scanning speed 400 nm/min and bandwidth 2 nm, equipped with 10 
mm matched quartz cells. 
Reagents and solutions  
All chemicals and reagents utilized were of an analytical degree from the 
Egyptian Pharmaceutical Industries Company (EIPICO), 
chlorphenoxamine hydrochloride (CPX) was getting. (CPX) standard 
solution has been prepared as 0.05% in acetonitrile for CLA, DDQ and 
TCNQ methods. All solutions were prepared daily. The working solution 
was prepared as required by suitable dilution of the stock solution. 
Chloranilic acid (CLA) obtained from Fluka, Switzerland, 5.0×10-3 M in 
acetonitrile. 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ) obtained 
from Aldrich, Sigma-Aldrich Chemie, Steinheim, Germany, 5.0×10-3 M in 
acetonitrile. 7,7,8,8-tetracyanoquinodimethane (TCNQ) obtained from 
Aldrich, Sigma-Aldrich Chemie, Steinheim, Germany, 5.0×10-3
Accurately weighed the amount of chlorphenoxamine-HC1 (CPX) 
(170.17 mg) equivalent to (151.92 mg) of CPX base which was 
 M in 
acetonitrile. Allergex tablets obtained from Egyptian International 
Pharmaceutical Industries Company (EIPICO), Egypt. Each tablet was 
labeled to contain 20 mg of CPX. 
Standard drug solution in free base form chlorphenoxamine 
hydrochloride (CPX) 
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dissolved in 50 ml water, transferred quantitatively to 250 ml 
separating funnel, the solution rendered alkaline by adding 5.0 ml of 
0.5 M Na2CO3 and the content was shaken for 5.0 min. The free base 
(CPX) formed was extracted with three 20 ml portions of chloroform, 
the extract was passed over anhydrous sodium sulfate and evaporated 
to dryness. The dissolution of the residue was in acetonitrile and 
transferred quantitatively to 50 ml volumetric flask. To mark, the 
volume was completed with acetonitrile and the final solution was 
diluted with acetonitrile to get a working concentration.  
Validation of methods  
According to linearity, accuracy, and precision, limit of detection, 
and quantification, the developed methods are confirmed according 
to the rules set by the International Conference on Harmonization 
ICH Q2 (R1) [15]. 
Linearity of calibration graphs 
Aliquots containing chlorphenoxamine-HC1 (CPX) in the working 
concentration range of 16-144 and 6-54, 4-76 µg/ml for CLA, DDQ, 
and TCNQ, respectively, were transferred into 10 ml volumetric 
flask. A 3.0 ml of 5.0×10-3M of each acceptor was added, the reaction, 
in the case of CLA and DDQ, was achieved instantaneously at room 
temperature (25±2 °C) and in the case of TCNQ heating at 40 °C for 
30 min was used. Dilution of the solutions was achieved by using 
acetonitrile. The absorbance of the resulting solutions was measured 
at the wavelengths of maximum absorption of 520, 460 and 840 nm 
for CLA, DDQ, and TCNQ, respectively, against reagent blank, treated 
similarly. The calibration graph was prepared by plotting 
absorbance versus concentration of CPX.  
Limit of detection, and quantification 
LOD is the lowest amount of analyte in the study or test sample that 
can be detected. LOQ is the lowest amount of analyte in the study or 
test sample that can be quantitatively determined by suitable 
precision and accuracy [16]. LOD and LOQ were determined by using 
the following equations designated by ICH guidelines. 
LOD = 3.3 s/k 
LOQ = 10 s/k 
Where s is the standard deviation of the absorbance measurements 
and k is the slope of the related calibration curve [17]. 
Accuracy and precision 
Accuracy and precision were determined by intraday and interday 
analysis of CPX. Accuracy was carried out to assure the closeness of 
the test results obtained by the analytical method to the true value 
[18] and precision was carried out to ascertain the reproducibility of 
results for the proposed method [19]. Samples were prepared in five 
replicates at three different concentrations within the Beer’s law 
limits and the absorbance of each concentration was recorded in five 
replicates (n=5). The results were reported as % RE and % RSD. 
Stoichiometric relationship 
Spectrophotometrically, by applying Job’s method of continuous 
variation [20] and mole ratio method [21], the reaction 
stoichiometry between chlorphenoxamine-HC1 (CPX) and CLA, DDQ, 
and TCNQ were determined. In Job’s method of continuous 
variations of equimolar solutions was employed: 5.0×10-3 M 
standard solutions of CPX and each of π-acceptors were used. A 
series of solutions was set up in which the whole volume of drug and 
acceptor was kept at 5.0 ml in the whole volume of 10 ml. The 
reagents were mixed in various ratios and completed as directed 
under the general methodology. In mole ratio method, the 
experiments were performed by mixing a fixed volume of CPX (2.0 
ml of 5.0×10-3M CPX) with different volumes of each reagent 
separately (0.5-4.0 ml of 5.0×10-3
Procedure for the commercial dosage form 
 M of CLA, DDQ or TCNQ) and 
completed as described under the general procedure. 
Recovery study was carried out to find the accuracy of the proposed 
method by addition of standard drug solution to a pre-analyzed 
tablet dosage form of CPX sample solution at three different 
concentration levels within the specified linearity and range [22].  
About 20 tablets of the pharmaceutical dosage form “allergex 
tablets” were powdered, then amount equivalent to (151.92 mg) of 
CPX base were accurately weighed and the details under “Standard 
drug solution in the free base form”, were followed to obtain a 
working concentration, as detailed under the general procedure. The 
% recovery by the proposed method was calculated by using the 
formula as given below:  
% Recovery = [(E − T)/P] × 100 
E: Total amount of drug estimated (μg/ml) after standard addition  
T: Amount of drug found in pre-analyzed tablet dosage form (μg/ml) 
P: Amount of pure drug added (μg/ml) 
RESULTS AND DISCUSSION 
Absorption spectra 
Chlorphenoxamine hydrochloride (CPX) yielded intense colors with 
CLA, DDQ, and TCNQ in acetonitrile, absorbing maximally at 
wavelengths, 520, 460 and 840 nm, respectively, and this was due to 
the reaction between CPX acting as n-donor (D) and CLA, DDQ, and 
TCNQ as π-acceptors [23] which lead to the formation of charge 
transfer complexes which showed in fig. 2. 
D (Donor) + A(Acceptor)
↔ (D − A)(CT −  complex)
Polar  solvent
�⎯⎯⎯⎯⎯⎯⎯� (A− + D+) colored radical anions 
Due to the high solvating power and high dielectric constant of 




Fig. 2: Absorption spectra of (a) CPX-CLA complex against 
reagent blank (b) CPX-DDQ complex against a reagent blank 
and (c) CPX-TCNQ complex against a reagent blank 
 
Optimization of reaction conditions  
So as to accomplish most sensitivity and selectivity, the proposed 
spectrophotometric techniques were optimized via carefully 
determining the different reaction factors affecting the reaction. The 
ideal experimental conditions were built up by studying the effect of 
one parameter on the absorbance values of colored species and in 
turn keeping the other parameter constant. 
Effect of diluting solvents  
Different solvents, for example, acetonitrile, acetone, methanol, 
water, ethyl acetate, diethyl ether, and dimethylformamide were 
used to determine the charge transfer reaction in order to optimize 
the most appropriate medium for that reaction. Acetonitrile was an 
ideal solvent for the charge transfer reaction due to its high 
dielectric constant which raises the maximum yield of radical anions, 
offering maximum sensitivity [24], high solvation power for CLA, 
DDQ and TCNQ and gave high absorbance power. Because of their 
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low absorbance or being precipitated on dilution, the other solvents 
were not appropriate as in fig. 3.  
 
 
Fig. 3: Effect of different solvents on color intensity of CPX 
complexes with CLA, DDQ, and TCNQ 
 
Effect of reagent concentration  
The effect of the reagent concentration on the intensity of the color 
developed at the selected wavelengths was studied by adding 
different amounts of the reagents to fixed concentrations of CPX. To 
produce maximum and repeatability color intensity, 3.0 ml of 
5.0×10-3 M of each reagent was being sufficient for this purpose. To 
reach equilibrium rapidly, the higher concentrations of the reagents 
were used thus minimizing the time required to attain maximum 





Fig. 4: (a) Effect of temperature on the color intensity of CPX 
complexes and (b) effect of heating time on color intensity of 
CPX-TCNQ complex at 40 °C 
Effect of heating time and temperature 
The optimum reaction time was determined by following the 
absorbance increment at the λmax of the formed complexes. Sample 
solutions containing CPX and blank were treated identically with 
the reagents within different time and temperature ranging from 
25 to 90 °C. The results obtained indicated that complete color 
development was attained instantaneously at room temperature 
(25±2 °C), for CLA and DDQ. Heating at a higher temperature led to 
a decrease in color intensity, this is attributed to characteristics of 
CT complexes, positions of CT bands, stabilities and 
thermodynamic parameters which indicated that complexes can 
be stabilized for a longer time at low temperatures [25] as 
described in fig. 4a. TCNQ charge-transfer complex was completely 
developed after heating in a water bath at 40 °C for 30 min in fig. 
4b.  
However, heating at 40 °C was chosen to construct the calibration 
curve as the higher temperature was found to affect the linearity and 
reproducibility. The formed complex was stable for no less than 2.0 
h, in this way allowing quantitative analysis to be done with good 
accuracy. 
The stoichiometry of the CT-complexes  
Job’s continuous variation [20] and mole ratio methods [21] were 
applied in order to determine the suitable ratio between 
chlorphenoxamine-HC1 (CPX) and CLA, DDQ, and TCNQ. The results 
showed that, the interaction between the investigated drug and each 
one of π-acceptors found to be 1:1 as shown in fig. 5a and 5b.  
This finding was anticipated by the presence of one basic electron 
donating center (nitrogen atom) in the CPX structure. Based on this 
fact, the reaction pathway for the formation of the CT complex was 





Fig. 5: The stoichiometric ratios of CPX: π-acceptors obtained by 
(a) Job's continuous variation method and (b) mole ratio 
method
Ramadan et al. 




Fig. 6: Probable reaction mechanisms for the reaction between CPX and CLA, DDQ, and TNCQ 
 
 
Fig. 7: Benesi-Hildebrand plots of CT complexes of CPX with 
CLA, DDQ, and TCNQ 
 
Association constants and standard free energy  
The association constant for the interaction of CPX with π-acceptors 
was estimated according to the Benesi-Hidelbrand equation when the 













Where [A0] and [D0] are the total concentrations of the acceptor 
and donor, respectively, AAD is the absorbance of the complex at 
the λmax, εAD is the molar absorptivity of the complex, and KCT is the 
association constant of the complex (l/mol). From the previous 
equation, on plotting the values of [A0]/AAD versus 1/[D0], a 
straight line was obtained in fig. 7, from which the association 
constant KCT were obtained in table 1. Due to the dissociation of 
the original donor-acceptor complex to the radical anion low 
values were obtained for the association constants which were 
characteristic for these complexes. 
To calculate the standard free energy change of complexation (ΔG °) 
from the formation constant (KCT), this equation was used [27]: 
∆G ° = −2.303 RT log Kct 
Where, ΔG ° is the free energy change of the complex (kJ/mol), R is 
the gas constant (1.987 cal/mol/deg), T is the absolute temperature 
( °C+273) and KCT is the formation constant of the CT complex 
(l/mol). The standard free energy of complexation, (ΔG °) was 
calculated as in table 1. 
Linearity  
Under the described experimental parameters for both the methods, 
by plotting the measured absorbance versus different concentration 
of the drug, calibration graphs were obtained and for getting the 
values of correlation coefficients, regression analysis was carried 
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out. The proposed methods adhere to Beer’s law and linear plots 
with low intercept and good correlation coefficients were obtained 
in the concentration ranges of 16-144, 6-54 and 4-76 μg/ml for 
determination of CPX with CLA, DDQ, and TCNQ, respectively. Other 
statistical parameters, namely intercept (b), slope (a), molar 
absorptivity and Sandell's sensitivity values were calculated as well 
and given in table 1. The small values of Sandell's sensitivity indicate 
the high sensitivity of the proposed method. The low values of 
detection (LOD) and quantification limits (LOQ) indicate the 
possibility of applying the proposed method in the routine analysis 
of the drugs under investigation. These results showed that by using 
DDQ as π acceptor, it was the more sensitive one in comparison with 
CLA and TCNQ. A comparison of the performances between the 
proposed methods and those of reported [3, 4, 6] for the studied 
drug was summarized in table 2, and it indicated that there was no 
significant difference between proposed and reported methods 
based on comparing the results of molar absorptivity which 
confirmed the highest sensitivity of the method. 
 
Table 1: Results obtained by the proposed methods for the determination of CPX using CLA, DDQ, and TCNQ 
Parameter CLA DDQ TCNQ 
Temperature, °C 25 25 40 
λmax, nm 520 460 840 
Beer's law limit, μg/ml 16-144 6-54 4-76 
Molar absorptivity, ×104l/mol/cm 0.30 0.68 0.58 
Sandell`s sensitivity, ng/cm 113.12 50.28 89.10 
Regression equationa A = a + bC 
Regression coefficient (r2) 0.9988 0.9991 0.9988 
Sy/x 12.93×10-3 9.77×10-3 6.50×10-3 
Sb 8.06×10-3 11.70×10-3 8.02×10-3 
Sa 0.14 0.18 0.27 
SD of slope (Sb) 1.93×10-4 3.90×10-4 1.94×10-4 
SD of intercept (Sa) 4.42×10-3 3.34×10-3 1.90×10-3 
LOQb, μg/ml 3.35 1.48 3.58 
LOD b, μg/ml 1.11 0.49 1.18 
Association constant, K (l/mol) 391.92 596.14 698.58 
Standard free energy, ΔG (kJ/mol) -3.54×10-3 -3.78×10-3 -4.07×10-3 
aA = a+bC, where A is the absorbance, C is the concentration in μg/ml, a is an intercept, b is a slope,blimit of quantification and detection was 
calculated according to the ICH guidelines. 
 
Table 2: Comparison of linear range and molar absorptivity for the studied drug with reported methods 
Drug Methods Concentration 
range, μg/ml 
Molar absorptivity,  
l/mol/cm 
Ref. 
CPX The colorimetric method by using rose bengal 2-40 0.34×104 6 
Spectrophotometric determination by molybdenum(V) thiocyanate ions 5-40 0.74×104 3 
Spectrophotometric determination by using alizarin red S 10-70 0.58×104 3 
Spectrophotometric determination by using picric acid 3.4-47.64 0.77×104 4 
Spectrophotometric determination by using phenol red 8.51-88.48 0.37×104 4 
Spectrophotometric determination by CLA 16-144 0.30×104 Proposed method 
Spectrophotometric determination by DDQ 6-54 0.65×104 Proposed method 
Spectrophotometric determination by TCNQ 4-76 0.58×104 Proposed method 
 
Limit of detection and quantification  
The limits of (LOD) and (LOQ) for the proposed methods were 
determined separately, with reliable accuracy and precision and the 
values were recorded in table 1 indicating that the methods 
developed were sensitive and without the interference of the 
excipients. 
Accuracy and precision  
The accuracy and precision of the proposed methods were 
presented in table 3. The results were reported as percentage 
relative error (RE %) and percentage relative standard deviation 
(RSD %) which indicated the accuracy and precision of methods, 
respectively. The RE % and RSD % values thus obtained was less 
than 1 % which gave good accuracy and precision of the methods. 
Application to the dosage form 
The proposed techniques were effectively applied to determine CPX 
in pharmaceutical preparations. To calculate the concentration of 
the studied drug, the corresponding calibration equation shown in 
table 1 was used. The ordinarily used excipients and additives in the 
pharmaceutical forms were found not to interfere in the analysis. 
The % recoveries of the examined drug in its formulation are 
summarized in table 4. 
 
Table 3: Evaluation of intra-day and inter-day accuracy and precision 
Reagent Taken μg/ml Intra-day (n = 5) Inter-day (n = 5) 
Recoverya, % RE, % RSD, % Recoverya, % RE, % RSD, % 
 
CLA 
32 99.999 0.500 -3.12×10-4 99.999 0.287 -3.12×10-4 
48 99.999 0.243 -2.08×10-5 99.999 0.428 -2.08×10-4 
64 100.009 0.287 8.75×10-3 100.002 0.353 1.56×10-4 
 
DDQ 
12 99.999 0.299 -8.33×10-4 99.999 0.299 -8.33×10-4 
24 99.999 0.184 -4.16×10-4 99.999 0.212 -1.25×10-3 
36 99.999 0.137 -2.77×10-4 99.999 0.137 -2.77×10-4 
 
TCNQ 
12 99.999 0.441 -8.33×10-3 99.999 0.342 -8.33×10-4 
28 99.999 0.413 -3.57×10-4 99.999 0.389 -3.57×10-4 
44 99.999 0.209 -2.27×10-4 99.999 0.209 -2.27×10-4 
%RE: percent relative error, %RSD: relative standard deviation, n = number of measurements. amean value of five determinations. 
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Table 4: Recovery of CPX in tablets by the proposed methods 
Drug 
formulation 










32 31.999 99.999 0.402 -3.12×10-4 
48 47.999 99.999 0.237 -2.08×10-4 
64 63.999 99.999 0.351 -1.56×10-4 
 
DDQ 
12 11.999 99.999 0.292 -8.33×10-4 
24 23.999 99.999 0.201 -4.16×10-4 
36 35.999 99.999 0.136 -2.77×10-4 
 
TCNQ 
12 11.999 99.999 0.386 -1.66×10-3 
28 27.999 99.999 0.389 -3.57×10-4 
44 43.999 99.999 0.290 -2.27×10-4 
amean value of five determinations, bRSD: relative standard deviation. cRE: relative error, dAllergex tablets, Egyptian International Pharmaceutical 
Industries Company (EIPICO), Egypt.  
 
CONCLUSION 
Three simple, accurate, sensitive and less time consuming visible 
spectrophotometric methods using CLA, DDQ, and TCNQ reagents 
were described for analyzing of CPX in pharmaceutical dosage 
forms. DDQ method was more sensitive than CLA, and TCNQ 
methods, as seen from the higher molar absorptivity. Thus, the 
proposed visible spectrophotometric methods were useful for the 
quality control and routine analysis of CPX in pharmaceuticals since 
there was no interference from the common excipients that might be 
found in pharmaceutical formulations. 
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